Results 231 to 240 of about 850,997 (356)

Disconnected Pancreatic Duct Syndrome in Complicated Necrotising Pancreatitis. [PDF]

open access: yesSultan Qaboos Univ Med J
Al Maqrashi N   +3 more
europepmc   +1 more source

Proteomics profiling of research models for studying pancreatic ductal adenocarcinoma

open access: gold
Mathilde Resell   +16 more
openalex   +1 more source

Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials

open access: yesCancer Communications, EarlyView.
Abstract Background Glecirasib, an inhibitor of Kirsten rat sarcoma viral oncogene homolog glycine‐to‐cysteine substitution at codon 12 (KRAS G12C), has exhibited clinical activity in non‐small‐cell lung cancer (NSCLC) and colorectal cancer (CRC).
Jian Li   +31 more
wiley   +1 more source

Mechanism and role of regulated cell death in tumor immunity and immunotherapy

open access: yesCancer Communications, EarlyView.
Abstract Cancer immune checkpoint inhibitors (ICIs) have brought breakthroughs, but only about one‐third of cancer patients benefit from ICIs. In recent years, targeting non‐apoptotic regulated cell death (RCD) subtypes, such as ferroptosis, necroptosis, autophagy, cuproptosis, and pyroptosis, has emerged as a novel strategy in cancer therapy due to ...
Jingwen Hu   +4 more
wiley   +1 more source

Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma [PDF]

open access: hybrid, 2017
Jukun Song   +6 more
openalex   +1 more source

The INSPECTOR study: enhanced feasibility for clinical translation of a multi‐cancer early detection method based on enzyme‐assisted high signal‐to‐noise ratio sequencing of methylated circulating tumor DNA

open access: yesCancer Communications, EarlyView.
Abstract Background Blood‐based cell‐free DNA (cfDNA) methylation testing has emerged as a promising approach for multi‐cancer early detection (MCED), holding the potential to improve cancer survival rates. However, traditional bisulfite‐based methods often encounter sensitivity limitations in detecting early‐stage malignancies or certain cancer types.
Hui‐Yan Luo   +37 more
wiley   +1 more source

Mild Dilatation of the Main Pancreatic Duct Is a Risk Factor for Progression to Pancreatic Cancer in High-Risk Individuals. [PDF]

open access: yesGastro Hep Adv
Diwan EA   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy